NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 40 filers reported holding NEUROCRINE BIOSCIENCES INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,694,590 | +17.7% | 3,125,000 | 0.0% | 0.16% | +13.3% |
| Q2 2023 | $3,989,479 | -5.8% | 3,125,000 | 0.0% | 0.14% | -4.0% |
| Q1 2023 | $4,235,941 | -14.6% | 3,125,000 | 0.0% | 0.15% | -34.6% |
| Q4 2022 | $4,960,077 | +39.8% | 3,125,000 | +25.0% | 0.23% | +41.6% |
| Q3 2022 | $3,547,000 | +113.7% | 2,500,000 | +100.0% | 0.16% | +177.6% |
| Q2 2022 | $1,660,000 | – | 1,250,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TENOR CAPITAL MANAGEMENT Co., L.P. | 45,447,000 | $60,497,000 | 1.31% |
| SHENKMAN CAPITAL MANAGEMENT INC | 4,366,000 | $5,924,000 | 0.54% |
| Aequim Alternative Investments LP | 7,609,000 | $10,088,000 | 0.43% |
| MACKAY SHIELDS LLC | 27,806,000 | $37,405,000 | 0.35% |
| Weiss Asset Management LP | 10,000,000 | $13,290,000 | 0.33% |
| WOLVERINE ASSET MANAGEMENT LLC | 13,230,000 | $17,541,000 | 0.13% |
| Polar Asset Management Partners Inc. | 7,500,000 | $9,942,000 | 0.10% |
| LORD, ABBETT & CO. LLC | 22,141,000 | $29,732,000 | 0.07% |
| Calamos Advisors LLC | 7,500,000 | $9,967,000 | 0.05% |
| D. E. Shaw & Co., Inc. | 39,270,000 | $52,046,000 | 0.04% |